Elsevier

Experimental Gerontology

Volume 32, Issues 4–5, July–October 1997, Pages 451-469
Experimental Gerontology

Effect of neuropeptides on cognitive function

https://doi.org/10.1016/S0531-5565(96)00159-3Get rights and content

Abstract

Recent evidence indicates that, in addition to the involvement of cholinergic and other neurotransmitter systems, various neuropeptides that occur in cortical and subcortical brain regions have a role in cognitive behavior. This evidence results largely from behavioral studies in rodents and other animals, following peptide administration and only in a very few cases from similar studies in human subjects. Several neuropeptides studied appear to enhance or produce changes conducive to improvement in cognitive performance and these include vasopressin, corticotrophin-releasing hormone (CRH), somatostatin, substance P, neuropeptide Y, and thyrotrophin-releasing hormone (TRH), while one peptide, galanin, has been reported to inhibit cognitive processes. Of those neuropeptides that improve performance, only TRH has been shown recently to attenuate the memory impairment of human subjects and Alzheimer patients treated with an anticholinergic drug, and this review describes a series of complimentary studies in adult and aged rodents that contribute to our understanding of the possible mechanisms involved in the role of TRH in cognition.

References (86)

  • H.C. Fibiger

    Cholinergic mechanisms in learning and memory and dementia: A review of recent evidence

    Trends Neurosci.

    (1991)
  • L.W. Fitzgerald et al.

    Morris water task impairment and hypoactivity following cystamine-induced reductions of somatostatin-like immunoreactivity

    Brain Res.

    (1989)
  • J.F. Flood et al.

    Modulation of memory processing by neuropeptide Y varies with brain injection site

    Brain Res.

    (1989)
  • C. Geula et al.

    Cortical cholinergic fibres in ageing and Alzheimer's disease. A morphometric study

    Neuroscience

    (1989)
  • B.S. Givens et al.

    Galanin in the medial septal area impairs working memory

    Brain Res.

    (1992)
  • J.J. Hagan et al.

    Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis

    Behav. Brain Res.

    (1988)
  • T. Hokfelt et al.

    Distribution of thyrotrophin-releasing hormone (TRH) in the central nervous system as revealed by immunohistochemistry

    Eur. J. Pharmacol.

    (1975)
  • A. Horita et al.

    TRH analogue MK771 reverses neurochemical and learning deficits in medial septal-lesioned rats

    Peptides

    (1989)
  • F.C. Kardon et al.

    Thyrotrophin-releasing hormone in rat spinal cord

    Brain Res.

    (1977)
  • A.J. Kastin et al.

    Improvement in mental depression with decreased thyrotrophin response after administration of TRH

    Lancet

    (1972)
  • A. Khan et al.

    NS-3, a TRH analogue reverses repeated ECS-induced deficits in water maze performance in the rat

    Pharmacol. Biochem. Behav.

    (1994)
  • L-Od. Koskinen

    Cerebral and peripheral blood flow effects of TRH in the ratĀ role of vagal nerves

    Peptides

    (1989)
  • T. Matsuishi et al.

    A pilot study on the anticonvulsive effects of a thyrotrophin-releasing hormone analogue in intractable epilepsy

    Brain Dev.

    (1983)
  • R.K. McNamara et al.

    The neuropharmacological and neurochemical basis of place learning in the Morris water maze

    Brain Res. Rev.

    (1993)
  • A.H. Mellow et al.

    A peptide enhancement strategy in Alzheimer's disease; Pilot study with TRH/physostigmine infusions

    Biol. Psychol.

    (1993)
  • J.E. Morley

    Extrahypothalamic thyrotrophin-releasing hormone (TRH)—Its distribution and its function

    Life Sci.

    (1979)
  • R.G.M. Morris

    Spatial localisation does not require the presence of local cues

    Learn. Mot.

    (1981)
  • R.G.M. Morris

    Developments of a water-maze procedure for studying spatial learning

    J. Neurosci. Methods

    (1984)
  • S.O. Ogren et al.

    Evidence for a role of the neuropeptide galanin in spatial learning

    Neuroscience

    (1992)
  • K.J. Page et al.

    Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-induced and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: Differential dependence on cholinergical neuronal loss

    Neuroscience

    (1991)
  • T. Sharp et al.

    A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues

    Regul. Pept.

    (1984)
  • T. Sharp et al.

    Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetised rat

    Neuropharmacology

    (1984)
  • D.B. Williams et al.

    Motor neurone disease (Amyotrophic Lateral Sclerosis)

  • M. Yamamoto et al.

    Effects of a new analogue of TRH on pentobarbital-induced sleep time in rodents

    Neuropharmacology

    (1989)
  • G.G. Yarbrough

    Thyrotrophin-releasing hormone and CHS cholinergic neurons

    Life Sci.

    (1983)
  • T.M. Ballard et al.

    Effect of TRH analogue, RX77368 on a working memory test in AMPA-induced septal-hippocampal lesioned rats

    J. Psychopharmacol.

    (1995)
  • T.M. Ballard et al.

    The TRH analogue, RX77368 improves working memory in AMPA-induced septal-hippocampal lesioned rats

    Br. J. Pharmacol.

    (1996)
  • T.M. Ballard et al.

    Effect of thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test

    Psychopharmacology

    (1996)
  • R.T. Bartus et al.

    The cholinergic hypothesis of geriatric memory dysfunction

    Science

    (1982)
  • M.F. Beal et al.

    Substance P like immunoreactivity is reduced in Alzheimer's disease cerebral cortex

    Neurology

    (1987)
  • G.W. Bennett et al.

    TRH-catecholamine interactions in brain and spinal cord

    Ann. NY Acad. Sci.

    (1989)
  • G. Bissette et al.

    Corticotrophin-releasing factor like immunoreactivity in senile dementia of the Alzheimer type

    JAMA

    (1985)
  • B.J. Cole et al.

    5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task

    Psychopharmacology (Berlin)

    (1994)
  • Cited by (68)

    • Functional neuroanatomy and disorders of cognition

      2020, Cognitive Informatics, Computer Modelling, and Cognitive Science: Volume 2: Application to Neural Engineering, Robotics, and STEM
    • TRH modulates glutamatergic synaptic inputs on CA1 neurons of the mouse hippocampus in a biphasic manner

      2016, Neuropharmacology
      Citation Excerpt :

      Collectively, these results suggest a TRH involvement in pathogenesis of depression. TRH also regulates cognitive functions (Bennett et al., 1997; Horita, 1998; Olson et al., 1995). TRH analogs are beneficial in animal models of amnesia and prevent the memory impairment caused by chronic ethanol administration and brain lesions (Ballard et al., 1996; Faden et al., 1999; Ogasawara et al., 1996; Sabbatini et al., 1998).

    • Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments

      2012, Neuropharmacology
      Citation Excerpt :

      Although TRH levels decrease in the hypothalamus in aging rats (Pekary et al., 1984), the levels seem to be preserved in healthy aging humans (Mazzoccoli et al., 2010) however, reduced levels are reported in AD (Luo et al., 2002). TRH can alter cognitive and emotional function (Bennett et al., 1997) and is prominently increased after electroconvulsive treatment (ECT), a widely used clinical intervention that is especially efficacious for severe melancholic and/or psychotic depression (Pekary et al., 1999) (reviewed in Sattin, 1999). ECT may also acutely inhibit GSK3 through the canonical mechanism of Akt activation (Kang et al., 2004; Roh et al., 2003) (Fig. 3).

    • Cognitive enhancers: Focus on modulatory signaling influencing memory consolidation

      2011, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      In some cases, these limitations are being circumvented by the development of intranasal formulations that allow efficient delivery of peptidergic molecules to the brain (Fehm et al., 2000). A general view of the role of neuropeptides in memory modulation has been presented in several reviews (Bennett et al., 1997; de Wied, 1997; Engelmann et al., 1996; Feany, 1996; Fehm et al., 2000; Gülpinar and Yegen, 2004; Huston and Hasenöhrl, 1995; Koob et al., 1989; Ogren et al., 2010). Here we will focus on the gastrin-releasing peptide (GRP) as an illustrative example of neuropeptide involved in modulating memory that can be targeted for cognitive enhancement.

    View all citing articles on Scopus
    View full text